611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Health Tip: Treating a Dog BiteVets With PTSD Face Higher Odds for Early Death From Multiple CausesFDA Expands Cystic Fibrosis Treatment Approval to Children Ages 6 to 12AHA News: Half of U.S. Adults Should Monitor Blood Pressure at Home, Study SaysWidely Prescribed Class of Meds Might Raise Dementia Risk9/11 Dust Linked to Prostate Cancer in First RespondersOcean Swimming Causes Skin Changes: StudyNew Drug Combats Leading Cause of DwarfismAHA News: What Migraine Sufferers Need to Know About Stroke RiskNorovirus Fears Stir Recall of Frozen BlackberriesFlying Insects in Hospitals Carry 'Superbug' GermsU.S. Cases of Infant Gut Illness Plummet After Vaccine IntroducedAHA News: This Faulty Gene May Help Predict Heart Muscle DiseaseCell Mapping Provides New Insights About AsthmaHealth Tip: Recognizing Balance DisordersThe Safer Way to Ease Post-Surgical PainLong Work Hours Tied to Higher Odds for StrokeSudden Death Can Occur Even in Well-Controlled EpilepsyStatins May Lower Risk of Stroke After Cancer RadiotherapyExperimental Drug Shows Early Promise Against Sickle Cell DiseaseFitness in Middle Age Cuts Men's Odds for COPD LaterVitamin D Supplements May Not Help Your HeartHow to Head Off a Pain in the NeckSprouts Supermarkets Recalls Frozen Spinach Due to Listeria FearsA-Fib Can Raise Dementia Risk, Even in Absence of StrokeAnother Climate Change Threat: More 'Flesh-Eating' Bacteria?Heading to Europe This Summer? Get Your Measles ShotAiling Heart Can Speed the Brain's Decline, Study FindsHealth Tip: Preventing GlaucomaHead Injuries Tied to Motorized Scooters Are Rising: StudyOverweight Kids Are at Risk for High Blood PressureHot Water Soak May Help Ease Poor Leg CirculationHealth Tip: Understanding RosaceaHealth Tip: Causes of Swollen Lymph NodesAHA News: Study Provides Rare Look at Stroke Risk, Survival Among American IndiansCDC Opens Emergency Operations Center for Congo Ebola OutbreakScared Safe: Pics of Sun's Damage to Face Boost Sunscreen UseNo Needle Prick: Laser-Based Test Hunts Stray Melanoma Cells in BloodBats Are Biggest Rabies Danger, CDC SaysEmgality Receives First FDA Approval for Treating Cluster HeadacheZerbaxa Approved for Hospital-Acquired Bacterial PneumoniaBlood From Previously Pregnant Women Is Safe for Donation: StudyStudy Refutes Notion That People on Warfarin Shouldn't Eat Leafy GreensCancer Survivors Predicted to Top 22 Million by 2030Your Guide to a Healthier Home for Better Asthma ControlHigh Blood Pressure at Doctor's Office May Be More Dangerous Than SuspectedAHA News: 3 Simple Steps Could Save 94 Million Lives WorldwideHealth Tip: Dealing With Motion SicknessHealth Tip: Symptoms of MeningitisRace Affects Life Expectancy in Major U.S. Cities
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

FDA Approves 1st Generic EpiPen

HealthDay News
by -- HealthDay staff
Updated: Aug 16th 2018

new article illustration

THURSDAY, Aug. 16, 2018 (HealthDay News) -- The first generic version of the EpiPen was approved by the U.S. Food and Drug Administration on Thursday, paving the way for more affordable versions of the lifesaving allergy emergency medication.

Though other injectors are available, this drug, made by Teva Pharmaceuticals USA, is the first the FDA has said is the equivalent of the EpiPen. It can be automatically substituted for EpiPen in pharmacies across the United States, the Washington Post reported.

With a new school season about to start, people have been reporting a shortage of EpiPens, the newspaper noted.

"Today's approval of the first generic version of the most widely prescribed epinephrine auto-injector in the U.S. is part of our longstanding commitment to advance access to lower cost, safe and effective generic alternatives once patents and other exclusivities no longer prevent approval," FDA Commissioner Dr. Scott Gottlieb said in an agency news release.

"This approval means patients living with severe allergies who require constant access to lifesaving epinephrine should have a lower-cost option, as well as another approved product to help protect against potential drug shortages," Gottlieb added.

The price of the drug and its launch date were not yet available, but the company's statement suggested it would not be in time for many parents who are scrambling to find EpiPens in their pharmacies now, the newspaper reported. Teva will market its generic epinephrine auto-injector in 0.3 milligram (mg) and 0.15 mg strengths.

EpiPen, made by Mylan, injects the hormone epinephrine into the thigh to reverse potentially fatal reactions to bee stings, peanuts and other allergens.

Although the key ingredient is cheap and the EpiPen was first approved in 1987, Mylan began increasing the price of the product, from less than $100 for a pack of two injectors in 2007 to $608 for a pair now. In response to criticism over the price of its drug, EpiPen introduced its own half-priced generic in 2016, the Post reported.